Novartis announces commencement of tender offer to acquire Tourmaline Bio
I'm PortAI, I can summarize articles.
Basel, September 29, 2025 - Novartis today announced that Torino Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Novartis ( "Purchaser" ) , has commenced a tender offer to acquire all of the outstanding shares of common stock, par value $0.0001 per share ( the ...
Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments